Johnson & Johnson

#NEWS: Today we announced an agreement to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders.    Building on our nearly 70-year legacy in neuroscience, this acquisition complements our current areas of focus in neuroscience, broadens our portfolio of transformational therapies and strengthens our ability to pioneer the next era of impactful and innovative medicines.    Please refer to today’s full announcement for key information and cautionary statements: https://lnkd.in/eNc4MTrC   #JNJ #Innovation  

Treatments for Sjögren’s disease, an autoantibody disease that causes damage to the body’s moisture glands, can help alleviate symptoms but not cure the disease itself. See how we’re finding ways to help target and reduce pathogenic autoantibodies that cause Sjögren’s symptoms before they appear: https://lnkd.in/eCrzQT22

"Leadership skills are developed to a high degree in the military. Leading with authority, leading peer groups, leading up—you know how to do it." U.S. Army veteran and Marketing manager Bob R. explains the unique value of our leadership development programs for transitioning veterans. Learn more, and join him: https://bit.ly/3Vw1vIM

Mentorship is a central element of our internal career development platform, which helps employees build skills and experience throughout the company. Join our Global Talent Hub to find roles where your growth is supported: https://bit.ly/4e7inwL

Do you know the difference between a heart attack and cardiac arrest? A heart attack occurs when blood flow to the heart is interrupted, causing heart tissue to die. Cardiac arrest is most commonly an electrical malfunction inside the heart. Both come on suddenly and can trigger similar symptoms. See the key facts—and how we’re advancing cardiovascular care: https://lnkd.in/er6-FyDx

Learning fuels us. That's why we invest in our employees' personal and professional development. It's part of our goal to make a lasting impact on health for humanity. Learn more: https://bit.ly/4fz9hJU 

With targeted therapies, physicians can treat a specific target—often a genetic variation—that only a select subset of patients carry. Explore how our research is shaping the future of healthcare: https://lnkd.in/eNcRGzHg

For over 20 years, our scientists have been dedicated to developing innovative treatments for multiple myeloma, a rare blood cancer that impacts more than 35,000 adults in the U.S. annually. Read more about our dedication to developing innovative treatments for the disease: https://lnkd.in/e_Gz28-N

Did you know: There are over 100 different types of arthritis that cause symptoms such as joint pain, swelling, stiffness and limited range of motion. Explore the 3 main types of arthritis and how we're accelerating the pace of research to treat them: https://lnkd.in/eKTbrary

The contributions of trailblazing women always play a critical role in the work that goes into tackling the world’s toughest health challenges. Meet just four of thousands across the globe working on innovations that impact health for humanity, and learn more about how you can join them:  https://bit.ly/3TzDQpZ